Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.39 USD | +4.51% | +3.73% | -24.46% |
May. 21 | Biodesix, Inc. to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting | CI |
May. 13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.46% | 202M | |
-22.57% | 7.93B | |
+75.90% | 4.54B | |
+8.70% | 2.77B | |
-2.98% | 2.62B | |
-50.41% | 1.99B | |
-18.51% | 1.7B | |
-20.12% | 1.47B | |
+19.61% | 1.23B | |
-45.78% | 1.1B |
- Stock Market
- Equities
- BDSX Stock
- News Biodesix, Inc.
- Transcript : Biodesix, Inc. Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-12-2023 12